Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation

Frontiers in Systems Neuroscience

Volumn 8, Issue MAY, 2014, Pages

  Lominac, Kevin D ^a   McKenna, Courtney L ^a   Schwartz, Lisa M ^a   Ruiz, Paige N ^a   Wroten, Melissa G ^a   Miller, Bailey W ^a   Holloway, John J ^a   Travis, Katherine O ^a   Rajasekar, Ganesh ^a   Maliniak, Dan ^a   Thompson, Andrew B ^a   Urman, Lawrence E ^a   Phillips, Tamara J ^b   Szumlinski, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Addiction vulnerability; Dopamine; Methamphetamine; Nucleus accumbens; Prefrontal cortex; Sensitization; Serotonin

Indexed keywords

BRAIN MONOAMINE; DOPAMINE; METHAMPHETAMINE; SEROTONIN;

ADDICTION; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM SENSITIZATION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEMALE; FOREBRAIN; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; MALE; MICRODIALYSIS; MONOAMINE RELEASE; MOUSE; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84900552926     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2014.00070     Document Type: Article

References (98)

1. Ago, Y., Nakamura, S., Kajita, N., Uda, M., Hashimoto, H., Baba, A., et al. (2007). Ritanserin reverses repeated methamphetamine-induced behavioral and neuro-chemical sensitization in mice. Synapse 61, 757-763.doi: 10.1002/syn.20421
2. Ago, Y., Nakamura, S., Uda, M., Kajii, Y., Abe, M., Baba, A., et al. (2006). Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51, 914-922.doi: 10.1016/j.neuropharm.2006.06.001
3. Ago, Y., Tanaka, T., Kita, Y., Tokumoto, H., Takuma, K., and Matsuda, T. (2012). Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release. Neuropharmacology 62, 1634-1639.doi: 10.1016/j.neuropharm.2011.10.004
4. Ares-Santos, S., Granado, N., and Moratalla, R. (2013). The role of dopamine receptors in the neurotoxicity of methamphetamine. J. Intern. Med. 273, 437-453.doi: 10.1111/joim.12049
5. Ary, A. W., Lominac, K. D., Wroten, M. G., Williams, A. R., Campbell, R. R., Ben-Shahar, O., et al. (2013). Imbalances in prefrontal cortex CC-Homer1 versus -Homer2 expression promote cocaine-seeking behavior. J. Neurosci. 33, 8101-8113.doi: 10.1523/JNEUROSCI.1727-12.2013
6. Berridge, K. C., and Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28, 309-369.doi: 10.1016/S0165-0173(98)00019-8
7. Bhatt, S. D., and Dluzen, D. E. (2005). Dopamine transporter function differences between male and female CD-1 mice. Brain Res. 1035, 188-195.doi: 10.1016/j.brainres.2004.12.013
8. Blum, K., Chen, A. L., Giordano, J., Borsten, J., Chen, T. J., Hauser, M., et al. (2012). The addictive brain: all roads lead to dopamine. J. Psychoactive Drugs 44, 134-143.doi: 10.1080/02791072.2012.685407
9. Broom, S. L., and Yamamoto, B. K. (2005). Effects of subchronic metham-phetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats. Psychopharmacology 181, 467-476.doi: 10.1007/s00213-005-0007-6
10. Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., et al. (2012). Toxicity of amphetamines: an update. Arch. Toxicol. 86, 1167-1231.doi: 10.1007/s00204-012-0815-5
11. Chen, J. C., Chen, P. C., and Chiang, Y. C. (2009). Molecular mechanisms of psychostimulant addiction. Chang Gung Med. J. 32, 148-154.
12. Cruickshank, C. C., and Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction 104, 1085-1099.doi: 10.1111/j.1360-0443.2009.02564.x
13. Dean, A. C., Groman, S. M., Morales, A. M., and London, E. D. (2013). An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology 38, 259-274.doi: 10.1038/npp.2012.179
14. Di Chiara, G. (1999). Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375, 13-30.doi: 10.1016/S0014-2999(99)00372-6
15. Engleman, E. A., Ingraham, C. M., O'Brien, C. E., McBride, W. J., and Murphy, J. M. (2004). Effect of housing conditions on sulpiride-induced increases in extracellular dopamine levels in the nucleus accumbens of alcohol-preferring (P) rats. Brain Res. 1022, 247-250.doi: 10.1016/j.brainres.2004.06.069
16. Espana, R. A., and Jones, S. R. (2013). Presynaptic dopamine modulation by stimulant self-administration. Front. Biosci. (Schol. Ed). 5, 261-276.
17. Fergusson, D. M., Horwood, L. J., Lynskey, M. T., and Madden, P. A. (2003). Early reactions to cannabis predict later dependence. Arch. Gen. Psychiatry 60, 1033-1039.doi: 10.1001/archpsyc.60.10.1033
18. Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., and Hanson, G. R. (2007). New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698.doi: 10.1146/annurev.pharmtox.47.120505. 105140
19. Ford, C. P. (2014). The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience.doi: 10.1016/j.neuroscience.2014. 01.025. [Epub ahead of print].
20. Fukakusa, A., Nagai, T., Mizoguchi, H., Otsuka, N., Kimura, H., Kamei, H., et al. (2008). Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens. J. Neurochem. 105, 436-444.doi: 10.1111/j.1471-4159.2007.05142.x
21. Galloway, M. P., Wolf, M. E., and Roth, R. H. (1986). Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J. Pharmacol. Exp. Ther. 236, 689-698.
22. Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U.S.A. 95, 9991-9996.doi: 10.1073/pnas.95.17.9991
23. Groman, S. M., and Jentsch, J. D. (2013). Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates. Curr. Opin. Neurobiol. 23, 625-631.doi: 10.1016/j.conb.2013.03.001
24. Groman, S. M., Lee, B., London, E. D., Mandelkern, M. A., James, A. S., Feiler, K., et al. (2011). Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J. Neurosci. 31, 7291-7299.doi: 10.1523/JNEUROSCI.0363-11.2011
25. Groman, S. M., Lee, B., Seu, E., James, A. S., Feiler, K., Mandelkern, M. A., et al. (2012). Dysregulation of D2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J. Neurosci. 32, 5843-5852.doi: 10.1523/JNEUROSCI.0029-12.2012
26. Halpin, L. E., Collins, S. A., and Yamamoto, B. K. (2014). Neurotoxicity of metham-phetamine and 3, 4-methylenedioxymethamphetamine. Life Sci. 97, 37-44.doi: 10.1016/j.lfs.2013.07.014
27. Hayen, A., Meese-Tamuri, S., Gates, A., and Ito, R. (2014). Opposing roles of prelimbic and infralimbic dopamine in conditioned cue and place preference. Psychopharmacology.doi: 10.1007/s00213-013-3414-0. [Epub ahead of print].
28. Herold, C. (2010). NMDA and D2-like receptors modulate cognitive flexibility in a color discrimination reversal task in pigeons. Behav. Neurosci. 124, 381-390.doi: 10.1037/a0019504
29. Huotari, M., Gogos, J. A., Karayiorgou, M., Koponen, O., Forsberg, M., Raasmaja, A., et al. (2002a). Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur. J. Neurosci. 15, 246-256.doi: 10.1046/j.0953-816x.2001.01856.x
30. Huotari, M., Santha, M., Lucas, L. R., Karayiorgou, M., Gogos, J. A., and Männistö, P. T. (2002b). Effect of dopamine uptake inhibition on brain cat-echolamine levels and locomotion in catechol-O-methyltransferase (COMT) disrupted mice. J. Pharmacol. Exp. Ther. 303, 1309-1316.doi: 10.1124/jpet.102. 043042
31. Ikeda, M., Ozaki, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., et al. (2007). Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav. 6, 107-112.doi: 10.1111/j.1601-183X.2006.00237.x
32. Jentsch, J. D., and Pennington, Z. T. (2014). Reward, interrupted: inhibitory control and its relevance to addictions. Neuropharmacology 76 (Pt B), 479-486.doi: 10.1016/j.neuropharm.2013.05.022
33. Ji, J., and Dluzen, D. E. (2008). Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J. Neural Transm. 115, 809-817.doi: 10.1007/s00702-007-0017-0
34. Johanson, C. E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., et al. (2006). Cognitive function and nigrostriatal markers in abstinent metham-phetamine abusers. Psychopharmacology 185, 327-338.doi: 10.1007/s00213-006-0330-6
35. Karoum, F., Chrapusta, S. J., and Egan, M. F. (1994). 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem. 63, 972-979.doi: 10.1046/j.1471-4159.1994.63030972.x
36. Kuhn, D. M., Angoa-Pérez, M., and Thomas, D. M. (2011). Nucleus accumbens invulnerability to methamphetamine neurotoxicity. ILAR J. 52, 352-365.doi: 10.1093/ilar.52.3.352
37. Laćan, G., Hadamitzky, M., Kuczenski, R., and Melega, W. P. (2013). Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration. Synapse 67, 476-488.doi: 10.1002/syn.21654
38. Lavalaye, J., Booij, J., Reneman, L., Harbraken, J. B., and van Royen, E. A. (2000). Effect of age and gender on dopamine transporter imaging with [123I] FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27, 867-869.doi: 10.1007/s002590000279
39. Le Cozannet, R., Markou, A., and Kuczenski, R. (2013). Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats. Eur. J. Neurosci. 38, 3487-3495.doi: 10.1111/ejn.12361
40. Lee, B., Groman, S., London, E. D., and Jentsch, J. D. (2007). Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 32, 2125-2134.doi: 10.1038/sj.npp.1301337
41. Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., et al. (2009). Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J. Neurosci. 29, 14734-11440.doi: 10.1523/JNEUROSCI.3765-09.2009
42. Liu, K., and Steketee, J. D. (2011). Repeated exposure to cocaine alters medial prefrontal cortex dopamine D2-like receptor modulation of gluta-mate and dopamine neurotransmission within the mesocorticolimbic system. J. Neurochem. 119, 332-341.doi: 10.1111/j.1471-4159.2011.07362.x
43. Liu, X., Chang, L., Vigorito, M., Kass, M., Li, H., and Chang, S. L. (2009). Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J. Neuroimmune Pharmacol. 4, 309-316.doi: 10.1007/s11481-009-9160-8
44. Lominac, K. D., Sacramento, A. D., Szumlinski, K. K., and Kippin, T. E. (2012). Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered versus non-contingently administered intravenous methamphetamine. Neuropsychopharmacology 37, 707-722.doi: 10.1038/npp.2011.248
45. Männistö, P. T., and Kaakkola, S. (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51, 593-628.
46. Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M., et al. (2003). Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116, 127-137.doi: 10.1016/S0306-4522(02)00556-0
47. McCann, U. D., and Ricaurte, G. A. (2004). Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci. Biobehav. Rev. 27, 821-826.doi: 10.1016/j.neubiorev.2003.11.003
48. McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., and Ricaurte, G. A. (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18, 8417-8422.
49. Morissette, M., and Di Paolo, T. (1993a). Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60, 1876-1883.doi: 10.1111/j.1471-4159.1993.tb13415.x
50. Morissette, M., and Di Paolo, T. (1993b). Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58, 16-22.doi: 10.1159/000126507
51. Morita, Y., Ujike, H., Tanaka, Y., Kishimoto, M., Okahisa, Y., Kotaka, T., et al. (2008). The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 54-58.doi: 10.1002/ajmg.b.30565
52. Mozley, L. H., Gur, R. C., Mozley, P. D., and Gur, R. E. (2001). Striatal dopamine transporters and cognitive functioning in healthy men and women. Am. J. Psychiatry 158, 1492-1499.doi: 10.1176/appi.ajp.158.9.1492
53. Paulson, P. E., and Robinson, T. E. (1995). Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19, 56-65.doi: 10.1002/syn.890190108
54. Paxinos, G., and Franklin, K. B. J. (2007). The Mouse Brain in Stereotaxic Coordinates. Maryland Heights, MO: Academic Press.
55. Petrakis, I. L., Limoncelli, D., Gueorguieva, R., Jatlow, P., Boutros, N. N., Trevisan, L., et al. (2004). Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am. J. Psychiatry 161, 1776-1782.doi: 10.1176/appi.ajp.161.10.1776
56. Phillips, T. J., Kamens, H. M., and Wheeler, J. M. (2008). Behavioral genetic contributions to the study of addiction-related amphetamine effects. Neurosci. Biobehav. Rev. 32, 707-759.doi: 10.1016/j.neubiorev.2007.10.008
57. Pierce, R. C., and Kalivas, P. W. (1997). Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17, 3254-3261.
58. Popova, N. K., Gilinskii, M. A., and Amstislavskaya, T. G. (2004). Effect of monoamine oxidase gene knockout on dopamine metabolism in mouse brain structures. Bull. Exp. Biol. Med. 137, 382-384.doi: 10.1023/B:BEBM.0000035137.97552.ab
59. Rivest, R., Falardeau, P., and Di Paolo, T. (1995). Brain dopamine transporter: gender differences and effects of chronic haloperidol. Brain Res. 692, 269-272.doi: 10.1016/0006-8993(95)00611-S
60. Robinson, T. E., and Becker, J. B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.doi: 10.1016/0165-0173(86)90002-0
61. Robinson, T. E., and Berridge, K. C. (2008). The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 3137-3146.doi: 10.1098/rstb.2008.0093
62. Rusyniak, D. E. (2011). Neurologic manifestations of chronic methamphetamine abuse. Neurol. Clin. 29, 641-655.doi: 10.1016/j.ncl.2011.05.004
63. Sam, P. M., and Justice, Jr. J. B. (1996). Effect of general microdialysis-induced depletion on extracellular dopamine. Anal. Chem. 68, 724-728.doi: 10.1021/ac950754+
64. Santiago, M., Machado, A., and Cano, J. (1993). Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists. Eur. J. Pharmacol. 239, 83-91.doi: 10.1016/0014-2999(93)90979-R
65. Schuckit, M. A., Tipp, J. E., Smith, T. L., Wiesbeck, G. A., and Kalmijn, J. (1997). The relationship between Self-Rating of the Effects of alcohol and alcohol challenge results in ninety-eight young men. J. Stud. Alcohol 58, 397-404.
66. Schwendt, M., Rocha, A., See, R. E., Pacchioni, A. M., McGinty, J. F., Kalivas, P., et al. (2009). Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J. Pharmacol. Exp. Ther. 331, 555-562.doi: 10.1124/jpet.109.155770
67. Segal, D. S., and Kuczenski, R. (2006). Human methamphetamine pharmacoki-netics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance. Neuropsychopharmacology 31, 941-955.doi: 10.1038/sj.npp.1300865
68. Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., et al. (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 158, 1206-1214.doi: 10.1176/appi.ajp.158.8.1206
69. Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., et al. (2003). Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 160, 1699-1701.doi: 10.1176/appi.ajp.160.9.1699
70. Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., and Levey, A. I. (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18, 2697-2708.
71. Shabani, S., Dobbs, L. K., Ford, M. M., Mark, G. P., Finn, D. A., and Phillips, T. J. (2012a). A genetic animal model of differential sensitivity to methamphetamine reinforcement. Neuropharmacology 62, 2169-2177.doi: 10.1016/j.neuropharm.2012.01.002
72. Shabani, S., Mckinnon, C. S., Cunningham, C. L., and Phillips, T. J. (2012b). Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology 62, 1134-1141.doi: 10.1016/j.neuropharm.2011.11.005
73. Shabani, S., McKinnon, C. S., Reed, C. R., Cunningham, C. L., and Phillips, T. J. (2011). Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake. Genes Brain Behav. 10, 625-636.doi: 10.1111/j.1601-183X.2011.00700.x
74. Shirayama, Y., and Chaki, S. (2006). Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr. Neuropharmacol. 4, 277-291.doi: 10.2174/157015906778520773
75. Shoblock, J. R., Maisonneuve, I. M., and Glick, S. D. (2003). Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology 170, 150-156.doi: 10.1007/s00213-003-1522-y
76. Staley, J. K., Krishnan-Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J. P., et al. (2001). Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41, 275-284.doi: 10.1002/syn.1084
77. Stephans, S. E., and Yamamoto, B. K. (1995). Effect of repeated methamphetamine administration on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 700, 99-106.doi: 10.1016/0006-8993(95)00938-M
78. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005). Mechanisms of neu-rotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406-433.doi: 10.1016/j.pneurobio.2005.04.003
79. Szumlinski, K. K., Liu, A., Penzner, J. H., and Lominac, K. D. (2007). Protracted "pro-addictive" phenotype produced by pre-adolescent phenyl-propanolamine. Neuropsychopharmacology 32, 1760-1773.doi: 10.1038/sj.npp. 1301306
80. Törnwall, M., and Männistö, P. T. (1993). Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur. J. Pharmacol. 250, 77-84.doi: 10.1016/0014-2999(93) 90623-P
81. Törnwall, M., Tuomainen, P., and Männistö, P. T. (1993). Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur. J. Pharmacol. 239, 39-45.doi: 10.1016/0014-2999(93) 90973-L
82. Tuomainen, P., Törnwall, M., and Männistö, P. T. (1996). Minor effect of tol-capone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Pharmacol. Toxicol. 78, 392-396.doi: 10.1111/j.1600-0773.1996. tb00224.x
83. Uhl, G. R., Drgon, T., Liu, Q. R., Johnson, C., Walther, D., Komiyama, T., et al. (2008). Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 65, 345-355.doi: 10.1001/archpsyc.65.3.345
84. Ujike, H., Onoue, T., Akiyama, K., Hamamura, T., and Otsuki, S. (1989). Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl.) 98, 89-92.doi: 10.1007/BF00442011
85. United Nations Office on Drugs and Crime. (2011). World Drug Report New York, NY: United Nations.
86. Vanderschuren, L. J., and Kalivas, P. W. (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensi-tization: a critical review of preclinical studies. Psychopharmacology 151, 99-120.doi: 10.1007/s002130000493
87. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M., et al. (2001b). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158, 2015-2021doi: 10.1176/appi.ajp.158.12.2015
88. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., et al. (2001a). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 9414-9418.
89. Wagner, G. C., Tekirian, T. L., and Cheo, C. T. (1993). Sexual differences in sensitivity to methamphetamine toxicity. J. Neural. Transm. Gen. Sect. 93, 67-70.doi: 10.1007/BF01244939
90. Westerink, B. H. C., and Cremers, T. I. H. F. (eds.). (2007). Handbook of Microdialysis: Methods, Applications and Clinical Aspects. London: Academic Press.
91. Wheeler, J. M., Reed, C., Burkhart-Kasch, S., Li, N., Cunningham, C. L., Janowsky, A., et al. (2009). Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes Brain Behav. 8, 758-771.doi: 10.1111/j.1601-183X.2009.00522.x
92. Wilkinson, L. S., Humby, T., Killcross, A. S., Torres, E. M., Everitt, B. J., and Robbins, T. W. (1998). Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur. J. Neurosci. 10, 1019-1026.doi: 10.1046/j.1460-9568.1998.00119.x
93. Wise, R. A. (2008). Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox. Res. 14, 169-183.doi: 10.1007/BF03033808
94. Yamamoto, B. K., and Bankson, M. G. (2005). Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17, 87-117.doi: 10.1615/CritRevNeurobiol.v17.i2.30
95. Yang, M. H., Jung, M. S., Lee, M. J., Yoo, K. H., Yook, Y. J., Park, E. Y., et al. (2008a). Gene expression profiling of the rewarding effect caused by methamphetamine in the mesolimbic dopamine system. Mol. Cells 26, 121-130.
96. Yang, M. H., Kim, S., Jung, M. S., Shim, J. H., Ryu, N. K., Yook, Y. J., et al. (2008b). Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict. Biol. 13, 287-294.doi: 10.1111/j.1369-1600.2007.00090.x
97. Yu, Y. L., and Wagner, G. C. (1994). Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. Park. Dis. Dement. Sect. 8, 215-221.doi: 10.1007/BF02260942
98. Zhang, Y., Loonam, T. M., Noailles, P. A., and Angulo, J. A. (2001). Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N. Y. Acad. Sci. 937, 93-120.doi: 10.1111/j.1749-6632.2001.tb03560.x